[Pulmonary and other aspergilloses in patients in the intensive care unit]

Mycoses. 2012 Jul:55 Suppl 2:25-9. doi: 10.1111/j.1439-0507.2012.02180.x.

[Article in German]

Author

Richard Strauß¹

Affiliation

¹ Medizinische Klinik 1, Universitätsklinikum Erlangen, Erlangen, Deutschland. richard.strauss@uk-erlangen.de

PMID: 22519629
DOI: 10.1111/j.1439-0507.2012.02180.x

No abstract available

MeSH terms

Antifungal Agents / therapeutic use
Aspergillosis / epidemiology
Aspergillosis / etiology
Aspergillosis / therapy
Glucocorticoids / therapeutic use
Humans
Intensive Care Units
Invasive Pulmonary Aspergillosis / epidemiology*
Invasive Pulmonary Aspergillosis / etiology
Invasive Pulmonary Aspergillosis / therapy
Liver Cirrhosis / complications
Nose Diseases / epidemiology
Nose Diseases / etiology
Nose Diseases / therapy
Prognosis
Pulmonary Disease, Chronic Obstructive / complications
Risk Factors

Substances

Antifungal Agents
Glucocorticoids